Skip to content

A study to compare the efficacy of oral Curcuma longa in pulmonary tuberculosis patients

Efficacy of oral Curcuma longa as an add on therapy with standard anti tuberculosis treatment compared to standard anti tuberculosis treatment alone in newly diagnosed sputum positive drug sensitive pulmonary tuberculosis patients – A randomized double blinded placebo controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060532
Enrollment
230
Registered
2023-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

None listed

Sponsors

Jawarhalal Institute of Post Graduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed smear positive drug sensitive pulmonary tuberculosis patients who have at least one sputum smear samples positive for tubercle bacilli (at least 1+) by auramine rhodamine staining- Patients willing to come for regular followup

Exclusion criteria

Exclusion criteria: -Patient with HIV -Patients diagnosed with Chronic Kidney disease and Chronic liver disease requiring dose modifications. -Pregnant and lactating women. -Newly diagnosed tuberculosis patients with respiratory failure

Design outcomes

Primary

MeasureTime frame
To compare the proportion of patients achieving sputum smear conversion at the end of 1 month between oral Curcuma longa as an add on therapy to standard anti tuberculosis treatment and placebo with standard anti tuberculosis treatment in newly diagnosed drug sensitive pulmonary tuberculosis patientsTimepoint: 0, 1 month

Secondary

MeasureTime frame
to compare adverse eventsTimepoint: 0, 1 month, 2 months, 6 months;to compare the change in inflammatory markersTimepoint: 0, 1 month;to compare treatment cureTimepoint: 0, 6 months

Countries

India

Contacts

Public ContactRakesh Chandrasegeran

Jawarhalal Institute of Post - Graduate Medical Education and Research

drmadhusmita1@gmail.com9789687488

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026